discontinued

BM3341 Lipoteichoic Acid (LTA) antibody

See related secondary antibodies

Search for all "Lipoteichoic Acid (LTA)"

0.2 mg / €350.00

Quick Overview

Mouse anti Lipoteichoic Acid (LTA) BDI701

BM3341

Product Description for Lipoteichoic Acid (LTA)

Mouse anti Lipoteichoic Acid (LTA) BDI701.
Presentation: Purified
Product is tested for Enzyme Immunoassay.

Properties for Lipoteichoic Acid (LTA)

Product Category Primary Antibodies
Quantity 0.2 mg
Presentation Purified
Applications E
Clonality Monoclonal
Clone BDI701
Host Mouse
Isotype IgG1
Shipping to Worldwide
PDF datasheet View Datasheet
Manufacturer Acris Antibodies GmbH
Material safety datasheet MSDS for Monoclonal Antibodies (de)

Datasheet Extract

Immunogen
Immunogen:
Staphylococcus epidermidis
Hay strain (ATCC #55133)
Isotype control AM03095PU-N
Application Suitable for use in ELISA (0.1-1.0 µg/ml) and Opsonization assay (80-160 µg/ml).
Concentration 1.4 mg/ml (OD280 nm, E0.1% = 1.4)
Storage Store the antibody at 2-8°C for one month or at -20°C for longer.
Avoid repeated freezing and thawing.
Shelf life: one year from despatch.
Format
Purification:
Protein G chromatography.
Buffer System:
PBS, pH 7.4 without preservatives.
State:
Liquid purified Ig fraction.
Purified
Specificity
Specificity:
Reacts with lipoteichoic acid of Staph. epidermidis, Hay strain and clinical strains of Staph. epidermidis (types I, II and III) and Staph. aureus strains 5 and 8.
Does not react with peptidoglycan of Staph. aureus or peptidoglycan-rhamnose, nor does it react with pneumococcal polysaccharides.
Does not cross-react with E. coli or H. influenza type B.
LTA is a major pro-inflammatory structure present within the cell wall layer of most gram-positive bacteria.

Accessory Products

  • LinkedIn